de Mazancourt P, Giudicelli Y
Brain Res. 1984 May 23;300(2):211-7. doi: 10.1016/0006-8993(84)90832-1.
In crude rat brain membranes, apparent adenylate cyclase activity tested in the absence of phosphodiesterase inhibitors was dose-dependently inhibited by the adenosine 'R-site' agonist N6-phenylisopropyladenosine (N6-PIA). In membranes from adrenalectomized rats, however, N6-PIA induced, under the same conditions, an activation. However, in the presence of the phosphodiesterase inhibitor Ro-20-1724, brain adenylate cyclase responsiveness to N6-PIA resulted in a dose-dependent inhibition in both sham-operated and adrenalectomized rats. Thus, the low KM cyclic AMP phosphodiesterase activity present in these brain membranes was investigated. Although this activity (tested in the presence of GTP) was unaltered by adrenalectomy, the dose-response curve of this enzyme to low concentrations of N6-PIA showed an activation in sham-operated and an inhibition in adrenalectomized rats, two effects which were suppressed by sodium (80 mM). These results showing that N6-PIA modulates both adenylate cyclase and cyclic AMP phosphodiesterase in the brain, provide an additional argument for a potential role of adenosine in the regulation of cyclic AMP metabolism in normal as well as in pathological brain.
在粗制大鼠脑膜中,在不存在磷酸二酯酶抑制剂的情况下检测到的腺苷酸环化酶活性受到腺苷“R位点”激动剂N6-苯基异丙基腺苷(N6-PIA)的剂量依赖性抑制。然而,在来自肾上腺切除大鼠的脑膜中,在相同条件下,N6-PIA却诱导了激活。然而,在存在磷酸二酯酶抑制剂Ro-20-1724的情况下,脑腺苷酸环化酶对N6-PIA的反应性在假手术和肾上腺切除大鼠中均导致剂量依赖性抑制。因此,对这些脑膜中存在的低Km环磷酸腺苷磷酸二酯酶活性进行了研究。尽管这种活性(在存在GTP的情况下检测)不受肾上腺切除术的影响,但该酶对低浓度N6-PIA的剂量反应曲线在假手术大鼠中显示激活,而在肾上腺切除大鼠中显示抑制,这两种效应均被钠(80 mM)抑制。这些结果表明N6-PIA在脑中调节腺苷酸环化酶和环磷酸腺苷磷酸二酯酶,为腺苷在正常和病理脑中环磷酸腺苷代谢调节中的潜在作用提供了额外的论据。